Immix Biopharma Stock Forecast - Daily Balance Of Power

IMMX Stock  USD 2.23  0.13  6.19%   
Immix Stock Forecast is based on your current time horizon.
  
Payables Turnover is likely to drop to 0 in 2024. Receivables Turnover is likely to drop to -330.82 in 2024. Common Stock Shares Outstanding is likely to drop to about 13.1 M in 2024. Net Loss is likely to drop to about (7.8 M) in 2024.
On September 29, 2023 Immix Biopharma had Daily Balance Of Power of (0.65). Balance of Power indicator (or BOP) measures the strength of Immix Biopharma market sensitivity to bulls and bears. It estimates the ability of Immix Biopharma buyers and sellers to push price to an extreme high or extreme low level. As a result, by monitoring Immix Biopharma Balance of Power indicator one can determine a trend of the price direction.
Check Immix Biopharma VolatilityBacktest Immix BiopharmaTrend Details  

Immix Biopharma Trading Date Momentum

On October 02 2023 Immix Biopharma was traded for  4.33  at the closing time. The top price for the day was 4.51  and the lowest listed price was  3.48 . The trading volume for the day was 1.6 M. The trading history from October 2, 2023 was a factor to the next trading day price jump. The trading delta at closing time against the next closing price was 26.61% . The trading delta at closing time against the current closing price is 39.77% .
Balance of Power indicator was created by Igor Livshin to predict asset short term price movements or warning signals. If Balance of Power indicator is trended towards the high of its range it will signify that the bulls are in control. On the other hand when the BOP indicator is moving towards the lows of its range it signifies that the bears are in control. If the indicator move from a high positive range to a lower positive range it signifies that the buying pressure is decreasing. Conversely, if the indicator move from a low negative range to a higher negative range it signifies that the selling pressure is decreasing.
Compare Immix Biopharma to competition

Other Forecasting Options for Immix Biopharma

For every potential investor in Immix, whether a beginner or expert, Immix Biopharma's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Immix Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Immix. Basic forecasting techniques help filter out the noise by identifying Immix Biopharma's price trends.

Immix Biopharma Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Immix Biopharma stock to make a market-neutral strategy. Peer analysis of Immix Biopharma could also be used in its relative valuation, which is a method of valuing Immix Biopharma by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Immix Biopharma Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Immix Biopharma's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Immix Biopharma's current price.

Immix Biopharma Market Strength Events

Market strength indicators help investors to evaluate how Immix Biopharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Immix Biopharma shares will generate the highest return on investment. By undertsting and applying Immix Biopharma stock market strength indicators, traders can identify Immix Biopharma entry and exit signals to maximize returns.

Immix Biopharma Risk Indicators

The analysis of Immix Biopharma's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Immix Biopharma's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting immix stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Immix Stock Analysis

When running Immix Biopharma's price analysis, check to measure Immix Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immix Biopharma is operating at the current time. Most of Immix Biopharma's value examination focuses on studying past and present price action to predict the probability of Immix Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immix Biopharma's price. Additionally, you may evaluate how the addition of Immix Biopharma to your portfolios can decrease your overall portfolio volatility.